Open-to-Accrual Therapeutic Trials

Gastrointestinal Cancer

Protocol ID

Official Title

PI Name

Lead CRC

Disease Site


NLG2104 NCT02077881 A Phase 1/2 Study of Indoximod in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Adenocarcinoma of the Pancreas A. Nayak Inquiries Pancreatic Cancer I/II
CALGB-80702 NCT01150045 A Phase III Trial of 6 Versus 12 Treatments of Adjuvant Folfox Plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer S. Ghamande Inquiries Colon Cancer III